Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

Sotalol 5-mg/mL Oral Suspension

Author(s):  Allen Loyd V Jr

Issue:  Sep/Oct 2011 - Volume 15, Number 5
View All Articles in Issue

Page(s):  425

Sotalol 5-mg/mL Oral Suspension Page 1

Download in electronic PDF format for $75

Abstract:  A formulation for preparing Sotalol 5-mg/mL Oral Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: Loyd V. Allen Jr., PhD, RPh, formulation, nonselective beta blocker, sotalol, ventricular arrhythmia, supraventricular tachycardia

Related Categories: FORMULATIONS, CARDIOLOGY, DOSAGE FORMS/DRUG CARRIERS

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Sotalol 5-mg/mL Oral Suspension
Allen Loyd V Jr
Sep/Oct 2011
Pg. 425

Compounding in the Pharmacy Curriculum: Beyond the Basics
Hinkle Amanda R
, Newton Gail D
May/Jun 2004
Pg. 181-185

Sotalol Hydrochloride 5-mg/mL Oral Liquid
Allen Loyd V Jr
Mar/Apr 2006
Pg. 144

Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh
Allen Loyd V Jr
Nov/Dec 2003
Pg. 449-450

Basics of Compounding for Cough
Allen Loyd V Jr
Nov/Dec 2004
Pg. 462-465

Compatibility of Baclofen, Carvedilol, Hydrochlorothiazide, Mercaptopurine, Methadone Hydrochloride, Oseltamivir Phosphate, Phenobarbital, Propranolol Hydrochloride, Pyrazinamide, Sotalol Hydrochloride, Spironolactone, Tacrolimus Monohydrate, Ursodeoxycholic Acid, and Vancomycin Hydrochloride Oral Suspensions Compounded with SyrSpend SF pH4
Polonini Hudson
, da Silva Sharlene Loures, Brandão Marcos Antônio Fernandes, Bauters Tiene, De Moerloose Barbara, Ferreira Anderson de Oliveira
Nov/Dec 2018
Pg. 516-526

Compounded Beta-blocker Nasal Spray for Treatment of Acute Migraine: A New Therapeutic Modality
Hagan John C III
, Everett Eric, Chamberlain Tyler
May/Jun 2020
Pg. 194-197

Labetalol Hydrochloride 5-mg/mL Injection
Allen Loyd V Jr
Mar/Apr 2012
Pg. 160

Carvedilol 1.25-mg/mL Oral Suspension
Allen Loyd V Jr
May/Jun 2006
Pg. 220

Stability of Sotalol Hydrochloride in Extemporaneously Prepared Oral Suspension Formulations
Sidhom Madiha B
, Rivera Nadya, Almoazen Hassan, Taft David R, Kirschenbaum Harold L
Sep/Oct 2005
Pg. 402-406

Esmolol Hydrochloride 10-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2012
Pg. 420

Metoprolol Tartrate 10 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
Nov/Dec 2021
Pg. 503

Propranolol 2 mg/mL or 5 mg/mL in Ora-Sweet
Allen Loyd V Jr
Nov/Dec 2021
Pg. 504

Propranolol 2 mg/mL and 5 mg/mL in Ora-Blend SF Suspension
Allen Loyd V Jr
Mar/Apr 2022
Pg. 148

A Compendium of Compounding Agents and Formulations, Part 5: Timolol and Beta-glucans
Riepl Mike
Sep/Oct 2022
Pg. 364-368

Procainamide Hydrochloride 100-mg/mL Injection
Allen Loyd V Jr
Jan/Feb 2014
Pg. 68

Propafenone 1.5-mg/mL Oral Liquid
Allen Loyd V Jr
Sep/Oct 2008
Pg. 455

Y-site Physical Compatibility of Beta-blocker Infusions with Intensive Care Unit Admixtures
Foushee Jaime A
, Meredith Pmichaele, Fox Laura M, Grace EdwardE
Jul/Aug 2016
Pg. 328-332

Infantile Hemangiomas, Part 2: Topical Treatment with Beta Blockers
Zur Eyal
Nov/Dec 2011
Pg. 458-463

Carvedilol 0.625-mg/mL Oral Liquid
Allen Loyd V Jr
Sep/Oct 2011
Pg. 418

Return to Top